CFR section

21 CFR 58.41: General

PART 58-GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES · Subpart C-Facilities

Key facts

Citation 21 CFR 58.41
Section General
Part PART 58-GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
Subpart Subpart C-Facilities
Subchapter 21 CFR A General
Product types cited General
Regulation text (excerpt) Each testing facility shall be of suitable size and construction to facilitate the proper conduct of nonclinical laboratory studies. It shall be designed so that there is a degree of separation that will prevent any function or activity from having an adverse effect on the study.

At a glance

  • 1–9 Inspections citing this section
  • None Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA